Related Experiment Video
Updated: May 31, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Renal amyloidosis caused by apolipoprotein A-II without a genetic mutation in the coding sequence
Ryuji Morizane1, Toshiaki Monkawa2, Konosuke Konishi2
1Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. morizanr@da2.so-net.ne.jp.
This study reports a rare case of apolipoprotein A-II (apoAII) amyloidosis in a patient without a family history or identified genetic mutation. Further research is needed to understand the causes of this hereditary kidney disease.
Area of Science:
- Nephrology
- Genetics
- Pathology
Background:
- Renal amyloidosis is typically caused by acquired light-chain or reactive systemic amyloid A.
- Hereditary amyloidosis, including apolipoprotein A-II (apoAII) amyloidosis, is less common and often undiagnosed.
- A genetic mutation in the apoAII stop codon is the presumed cause of apoAII amyloidosis.
Observation:
- A 68-year-old man presented with progressive proteinuria (6 g/day) over one year.
- Renal biopsy revealed amyloid deposition in glomeruli, excluding common causes.
- Immunohistochemistry confirmed apoAII deposition, but genetic sequencing found no mutations in the apoAII coding sequence.
Findings:
- This case describes apoAII amyloidosis in a patient lacking a family history and identifiable genetic mutation in the apoAII coding sequence.
- The findings suggest potential non-coding sequence mutations or other genetic mechanisms contributing to apoAII amyloid fibril formation.
Implications:
- The study expands the understanding of apoAII amyloidosis etiology beyond known coding sequence mutations.
- Further investigation is warranted to elucidate the full spectrum of genetic factors and diagnostic pathways for apoAII amyloidosis.
- This case underscores the importance of considering rare hereditary forms of amyloidosis even in the absence of typical genetic markers.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment

